Compare Stocks

→ AI “wealth window” is closing June 25th (From Paradigm Press) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARYD ARYA Sciences Acquisition Corp IV	$11.37 +0.2%	$11.28	$10.43 ▼ $11.39	$85.73M	-0.01	45,243 shs	319 shs
CERO CERo Therapeutics	$1.23 -5.4%	$2.03	$1.21 ▼ $12.80	$18.11M	-0.08	884,715 shs	66,682 shs
FHLT Future Health ESG	$12.00	$11.45	$9.97 ▼ $15.05	$71.23M	-0.12	9,336 shs	10 shs
PRE Prenetics Global	$5.17 -6.2%	$4.42	$2.85 ▼ $15.90	$47.25M	-0.28	99,157 shs	17,703 shs

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARYD ARYA Sciences Acquisition Corp IV	+0.18%	+0.18%	+0.44%	+2.06%	+9.01%
CERO CERo Therapeutics	-5.38%	-10.87%	-35.60%	+122,999,900.00%	+122,999,900.00%
FHLT Future Health ESG	-5.75%	-5.75%	-5.36%	-2.84%	+13.44%
PRE Prenetics Global	-6.17%	+5.30%	+36.77%	+10.00%	-59.45%

Biden replacement revealed? (Ad)

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARYD ARYA Sciences Acquisition Corp IV	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CERO CERo Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FHLT Future Health ESG	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PRE Prenetics Global	1.1812 of 5 stars	3.5	3.0	0.0	0.0	0.6	0.0	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARYD ARYA Sciences Acquisition Corp IV	N/A	N/A	N/A	N/A
CERO CERo Therapeutics	N/A	N/A	N/A	N/A
FHLT Future Health ESG	N/A	N/A	N/A	N/A
PRE Prenetics Global	3.00	Buy	$9.00	74.08% Upside

Current Analyst Ratings

Latest PRE, CERO, FHLT, and ARYD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/4/2024	PRE Prenetics Global	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$10.00 ➝ $9.00

(Data available from 5/9/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARYD ARYA Sciences Acquisition Corp IV	N/A	N/A	N/A	N/A	($3.49) per share	N/A
CERO CERo Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A
FHLT Future Health ESG	N/A	N/A	N/A	N/A	($1.56) per share	N/A
PRE Prenetics Global	$21.74M	2.17	N/A	N/A	$23.00 per share	0.22

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARYD ARYA Sciences Acquisition Corp IV	-$2.13M	N/A	0.00	∞	N/A	N/A	-9.83%	-5.41%	N/A
CERO CERo Therapeutics	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
FHLT Future Health ESG	-$50K	N/A	0.00	∞	N/A	N/A	-9.79%	-0.28%	N/A
PRE Prenetics Global	-$62.72M	-$4.80	N/A	∞	N/A	-193.60%	-11.15%	-9.03%	6/3/2024 (Estimated)

Latest PRE, CERO, FHLT, and ARYD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/1/2024	Q4 2023	PRE Prenetics Global	N/A	-$0.52	-$0.52	$0.53	N/A	$5.43 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARYD ARYA Sciences Acquisition Corp IV	N/A	N/A	N/A	N/A	N/A
CERO CERo Therapeutics	N/A	N/A	N/A	N/A	N/A
FHLT Future Health ESG	N/A	N/A	N/A	N/A	N/A
PRE Prenetics Global	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARYD ARYA Sciences Acquisition Corp IV	N/A	0.01	0.01
CERO CERo Therapeutics	N/A	N/A	N/A
FHLT Future Health ESG	N/A	0.02	0.02
PRE Prenetics Global	N/A	2.37	2.29

Ownership

Institutional Ownership

Company	Institutional Ownership
ARYD ARYA Sciences Acquisition Corp IV	48.08%
CERO CERo Therapeutics	29.64%
FHLT Future Health ESG	24.57%
PRE Prenetics Global	25.01%

Insider Ownership

Company	Insider Ownership
ARYD ARYA Sciences Acquisition Corp IV	53.45%
CERO CERo Therapeutics	15.80%
FHLT Future Health ESG	57.20%
PRE Prenetics Global	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ARYD ARYA Sciences Acquisition Corp IV	3	7.54 million	3.51 million	Not Optionable
CERO CERo Therapeutics	8	14.72 million	12.40 million	N/A
FHLT Future Health ESG	2,021	5.94 million	2.54 million	Not Optionable
PRE Prenetics Global	400	9.14 million	N/A	Not Optionable

PRE, CERO, FHLT, and ARYD Headlines

Source	Headline
	Aitrasound® Medical Group Announces Completion of a Pre-A Financing Round of Nearly 60 Million Hong Kong Dollars zawya.com - April 26 at 2:05 AM
	Dow Down Triple Digits; Tesla Props Up Nasdaq schaeffersresearch.com - April 26 at 2:05 AM
	Prenetics Global Stock (NASDAQ:PRE), Analyst Ratings, Price Targets, Predictions benzinga.com - April 6 at 11:24 PM
	Prenetics Flat on Financial Results baystreet.ca - April 3 at 2:29 PM
	Prenetics Global Limited: Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results finanznachrichten.de - April 1 at 5:08 PM
	Prenetics Global: Q4 Earnings Insights benzinga.com - April 1 at 5:08 PM
	PRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023 investorplace.com - April 1 at 2:08 PM
	Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results globenewswire.com - April 1 at 7:30 AM
	Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station finance.yahoo.com - February 9 at 11:02 AM
	Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station globenewswire.com - February 9 at 9:25 AM
	Prenetics Global files to sell 1.48M Class A shares for holders msn.com - January 17 at 5:24 PM
	Prenetics Global (PRE) Earnings Dates & Reports investing.com - December 18 at 10:10 AM
	PRENW Prenetics Global Limited WT EXP 051827 seekingalpha.com - December 17 at 10:46 PM
	Prenetics Global Stock (NASDAQ:PRE) Insider Trades benzinga.com - November 20 at 2:49 PM
	Prenetics Global GAAP EPS of -$0.08, revenue of $4.86M msn.com - November 20 at 2:49 PM
	Prenetics Global: Q3 Earnings Insights benzinga.com - November 20 at 9:49 AM
	Prenetics Announces Third Quarter 2023 Financial Results finance.yahoo.com - November 20 at 9:49 AM
	Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near? finance.yahoo.com - November 11 at 2:08 PM
	Prenetics Global Ltd Class A PRE morningstar.com - November 5 at 5:45 PM
	Prenetics Global announces reverse stock split msn.com - November 1 at 8:48 AM
	Prenetics Global Limited Announces Reverse Stock Split finance.yahoo.com - November 1 at 8:48 AM
	Prenetics Global Limited - Ordinary Shares - Class A money.usnews.com - October 30 at 11:26 PM
	A shift away from paycheck-driven mindset: How to win talent amidst global competition humanresourcesonline.net - October 26 at 12:20 AM
	Computer Weekly announces the Most Influential Women in UK Tech 2023 computerweekly.com - October 11 at 2:54 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

How to Use Put Debit Spreads to Profit From Falling Stocks
April 26, 2024 9:30 AM
View How to Use Put Debit Spreads to Profit From Falling Stocks
Power Surge: Utilities Sector's Resilience Shines
April 25, 2024 9:51 AM
View Power Surge: Utilities Sector's Resilience Shines
Breakout Alert: Coinbase's Consolidation Is About To End
April 12, 2024 9:45 AM
View Breakout Alert: Coinbase's Consolidation Is About To End
Here are the Pros and Cons of Using Options Call Debit Spreads
April 11, 2024 11:03 PM
View Here are the Pros and Cons of Using Options Call Debit Spreads
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
April 19, 2024 8:59 AM
View Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

All Headlines

Company Descriptions

ARYA Sciences Acquisition Corp IV

NASDAQ:ARYD

Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors. The company was incorporated in 2020 and is based in New York, New York.

CERo Therapeutics

NASDAQ:CERO

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Future Health ESG

NASDAQ:FHLT

Future Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.

Prenetics Global

NASDAQ:PRE

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial